1,10-phenanthroline has been researched along with pyrithione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT | 1 |
Forbes, IJ; Giannakis, C; Zalewski, PD | 1 |
2 other study(ies) available for 1,10-phenanthroline and pyrithione
Article | Year |
---|---|
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc | 2011 |
Physiological role for zinc in prevention of apoptosis (gene-directed death).
Topics: Cations, Divalent; Cell Death; Chelating Agents; Chromatography, Gel; Colchicine; DNA; Ethylenediamines; Leukemia, Lymphocytic, Chronic, B-Cell; Microscopy, Phase-Contrast; Phenanthrolines; Phorbol Esters; Pyridines; Sulfates; Thiones; Tumor Cells, Cultured; Zinc; Zinc Sulfate | 1991 |